Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Bayer Aktiengesellschaft (BAYRY) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Bayer Aktiengesellschaft is one of 885 individual stocks in the Medical sector. Collectively, these companies sit at #9 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy).The Zacks Consensus Estimate for BAYRY's full-year earnings has moved 4% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.Based on the latest available data, BAYRY has gained about 4% so far this year. At the same time, Medical stocks have lost an average of 2.7%. This means that Bayer Aktiengesellschaft is performing better than its sector in terms of year-to-date returns.Cardinal Health (CAH) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 13.4%.In Cardinal Health's case, the consensus EPS estimate for the current year increased 4.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry, which includes 11 individual stocks and currently sits at #75 in the Zacks Industry Rank. On average, stocks in this group have gained 5.4% this year, meaning that BAYRY is slightly underperforming its industry in terms of year-to-date returns. On the other hand, Cardinal Health belongs to the Medical - Dental Supplies industry. This 13-stock industry is currently ranked #84. The industry has moved -3.6% year to date.Going forward, investors interested in Medical stocks should continue to pay close attention to Bayer Aktiengesellschaft and Cardinal Health as they could maintain their solid performance.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.See Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks